Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Zelira Therapeutics.
RELATED STOCKHEAD STORIES
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech
Zelda might have found way forward for diagnosing breast cancer
Health & Biotech
The Pot Seat: Botanix’s Matt Callahan says synthetics are the future of cannabis drugs
Health & Biotech
Zelda’s looking for experts to help with its cannabis trials on kids and insomniacs
Health & Biotech
If pot is so hot, why aren’t cannabis directors buying their own companies?
News
Lunchtime ASX small cap wrap: who’s nursing a new years hangover
Health & Biotech
Suda signs deal with $936bn pharma company to sell its insomnia spray
Health & Biotech
Zelda and viagra mouth spray maker Suda team up to do pot
Health & Biotech
Weed week: Asia is cottoning on to cannabis. And does pot = thalidomide?
Health & Biotech
Zelda tries out weed to reduce opioid dependence
Escrow Watch
Escrow Watch: 678m shares about to flock onto the ASX
Health & Biotech
Weed week: here’s all the news driving the cannabis market (including hemp gin)
Health & Biotech
Heaps of Zelda shares are coming out of escrow – but the founders are keeping them
Health & Biotech
Weed week: here’s all the news driving ASX cannabis stocks
Health & Biotech
Weed week: it’s reefer madness as global pot stocks pass $6b in fund raising
Health & Biotech
It’s breast cancer awareness month – here are 10 ASX biotechs tackling the disease
Health & Biotech